Are CSL shares likely to go up from here? The post Down 11% in 2025, are CSL shares a good buy right now? appeared first on The Motley Fool Australia.

Carlisle Companies Incorporated (NYSE:CSL) today published its 2024 Annual Report, highlighting Carlisle’s strategic pivot to a pure play building products company as well as progress ...

Achieve market success faster with scalable technology from Biopharma Group, the exclusive UK and Ireland distributor for Avestin high pressure homogenisers. The race is on for biotech companies – to ...

Morgan Stanley initiated coverage of CSL (CSLLY) with an Overweight rating and A$313 price target A “solid revenue growth outlook” and margin recovery for CSL Behring underpin group EPS growth ...

MONTREAL, March 18, 2025 (GLOBE NEWSWIRE) -- The CSL Group (“CSL”), a global leader in responsible marine transportation, is excited to announce it has been named one of Montreal’s Top ...

MONTREAL, March 18, 2025 (GLOBE NEWSWIRE) -- The CSL Group (“CSL”), a global leader in responsible marine transportation, is excited to announce it has been named one of Montreal’s Top Employers for ...

CSL), saw declines. Despite strong demand for weight-loss treatments and high-profile acquisitions, the sector faced uncertainty due to shifting US policies and regulatory pressures. All the news that ...

Matter of fact, this biotech and its partner are in the process of advancing several studies under this specific program targeting this specific group of patients. The most notable study I want to ...

Learn More The CSL Ltd (ASX: CSL) share price is down 1.6% to $255.51 per share on Monday. The ASX 200 biotech is in the red today because its shares have begun trading ex-dividend. The CSL share ...